cocamidopropyl pg-dimonium chloride phosphate hamilelikte güvenli mi?
No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
Pregnancy-safe products containing cocamidopropyl pg-dimonium chloride phosphate










Related ingredients
Frequently asked questions
- cocamidopropyl pg-dimonium chloride phosphate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
- cocamidopropyl pg-dimonium chloride phosphate emzirirken güvenli mi?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific toxicity in authoritative sources, and no mechanistic data indicating mammary transfer. Topical use implies low but measurable exposure; therefore breastfeeding exposure considered low.
- cocamidopropyl pg-dimonium chloride phosphate bebek cildi için güvenli mi?
- No infant‑specific hazard data identified. Because infant skin (0–3 yr) has a higher surface‑area‑to‑weight ratio and a less mature barrier, exposure score is increased by +1 versus adult (low → moderate). No evidence was found that infant exposure leads to systemic reproductive/mechanistic effects.
- VeriMom cocamidopropyl pg-dimonium chloride phosphate nasıl puanlıyor?
- VeriMom cocamidopropyl pg-dimonium chloride phosphate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte cocamidopropyl pg-dimonium chloride phosphate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.